West Georgia Street
Suite 1055 1500 Royal Centre P.O. Box 11117
Vancouver, BC V6E 4N7
Full Time Employees:
|Mr. Fabio Chianelli||CEO & Chairman||N/A||N/A||1978|
|Mr. Carmelo Marrelli ACIS, B.Comm., CA, CGA, CPA||Chief Financial Officer||N/A||N/A||1971|
|Mr. Andrew Todd||Corp. Sec.||N/A||N/A||1958|
PharmaTher Holdings Ltd., a clinical-stage psychedelics biotech company, focuses on the research, development, and commercialization of novel uses, formulations, and delivery methods of psychedelics to treat mental illness, neurological, and pain disorders. The company's products in pipeline include Ketamine, which is in Phase I and II clinical trials for Parkinson's disease indications, as well as in preclinical trials for ALS-Lou Gehrig's disease indications; and KETABET, which is in Phase I and II clinical trials for mental health, neurological, and pain disorders. It is also developing microneedle patches for the delivery of antivirals for the treatment of influenza; and NCEs for multiple indications. The company is headquartered in Vancouver, Canada.
PharmaTher Holdings Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.